Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 112 (4), 966-78

Effects of Systemic, Intracerebral, or Intrathecal Administration of an N-methyl-D-aspartate Receptor Antagonist on Associative Morphine Analgesic Tolerance and Hyperalgesia in Rats

Affiliations

Effects of Systemic, Intracerebral, or Intrathecal Administration of an N-methyl-D-aspartate Receptor Antagonist on Associative Morphine Analgesic Tolerance and Hyperalgesia in Rats

G P McNally et al. Behav Neurosci.

Abstract

A flavor paired with morphine shifted to the right the function relating morphine dose to tail-flick latencies and provoked hyperalgesic responses when rats were tested in the absence of morphine. These learned increases in nociceptive sensitivity were not mediated by alterations in tail-skin temperature. Microinjection of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist D,L-2-amino-5-phosphonopentanoic acid (AP-5) into the lateral ventricle reversed the hyperalgesic responses but spared the tolerance to morphine analgesia. By contrast, systemic administration of the noncompetitive NMDA receptor antagonist MK-801 or intrathecal infusion of AP-5 reversed the hyperalgesic responses as well as the tolerance to morphine analgesia. The results demonstrate that associatively mediated tolerance to morphine analgesia can co-occur with hyperalgesic responses and are discussed relative to learned activation of endogenous pronociceptive mechanisms.

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback